BARD1 and breast carcinoma: In contrast to the association between BRCA1/BARD1 mutation and increased risk of basal-like breast cancer, the analysis of multiple independent data sets showed that the expression of BARD1 and BRCA1 is associated with poor prognosis in ER-positive breast cancer patients, but not in ER-negative ones.